Insider · CIK 0001603704
Michael Aaron Leabman
Files at MOVE (Corvex, Inc.). First filing Jan 12, 2026, latest Jan 14, 2026.
Michael Aaron Leabman files SEC Form 4 as officer and director at MOVE (Corvex, Inc.). Since Jan 12, 2026, Michael Aaron Leabman has reported 0 open-market buys worth $0 and 2 open-market sells worth $140k, the latest filed on Jan 14, 2026.
A track record needs three past buys with six months of prices behind them; Michael Aaron Leabman has 0, so none is measured yet.
The newest scored trade: sold $84k of MOVE on Jan 12, 2026, filed Jan 14, 2026, scored 49 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $140k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MOVE: Corvex, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 49Moderate | Corvex, Inc. | $84k 12,298 shares | -35% | - | |
| 27Weak | Corvex, Inc. | $56k 7,669 shares | -18% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | MOVE Corvex, Inc. | AGrant or award Common Stock | +11,174 | $0.00 | $0 | 33,813 | Jan 22, 2026 |
| Jan 12, 2026 | MOVE Corvex, Inc. | SOpen-market sale Common Stock | -3,377 | $7.01 | $24k | 31,560 | Jan 14, 2026 |
| Jan 13, 2026 | MOVE Corvex, Inc. | SOpen-market sale Common Stock | -2,076 | $6.94 | $14k | 29,484 | Jan 14, 2026 |
| Jan 14, 2026 | MOVE Corvex, Inc. | SOpen-market sale Common Stock | -6,845 | $6.66 | $46k | 22,639 | Jan 14, 2026 |
| Jan 6, 2026 | MOVE Corvex, Inc. | MOption exercise Common Stock | +42,250 | $1.25 | $53k | 42,606 | Jan 12, 2026 |
| Jan 7, 2026 | MOVE Corvex, Inc. | SOpen-market sale Common Stock | -3,293 | $7.34 | $24k | 39,313 | Jan 12, 2026 |
| Jan 8, 2026 | MOVE Corvex, Inc. | SOpen-market sale Common Stock | -3,593 | $7.26 | $26k | 35,720 | Jan 12, 2026 |
| Jan 9, 2026 | MOVE Corvex, Inc. | SOpen-market sale Common Stock | -783 | $7.27 | $5,692 | 34,937 | Jan 12, 2026 |
| Jan 6, 2026 | MOVE Corvex, Inc. | MOption exercise Stock Options (Right to Buy)derivative | -42,250 | $0.00 | $0 | 0 | Jan 12, 2026 |
| Nov 3, 2025 | MOVE Corvex, Inc. | DDisposition to issuer Common Stock | -21,260 | $0.00 | $0 | 356 | Nov 10, 2025 |
| Nov 3, 2025 | MOVE Corvex, Inc. | AGrant or award Stock option (right to buy)derivative | +42,250 | $0.00 | $0 | 42,250 | Nov 10, 2025 |
| Jul 3, 2025 | MOVE Corvex, Inc. | AGrant or award Common Stock | +139,925 | $0.00 | $0 | 216,163 | Jul 3, 2025 |
| May 9, 2025 | MOVE Corvex, Inc. | AGrant or award Common Stock | +72,674 | $0.00 | $0 | 76,238 | May 13, 2025 |
Questions about Michael Aaron Leabman
Answered from the filings on this page, as of the latest one.
Is Michael Aaron Leabman buying or selling?
In the last 12 months Michael Aaron Leabman reported 0 open-market buys worth $0 and 2 open-market sells worth $140k on SEC Form 4; the latest was sold $84k of MOVE on Jan 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael Aaron Leabman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Aaron Leabman has 0.
Where does Michael Aaron Leabman file Form 4?
Michael Aaron Leabman has filed Form 4 at MOVE (Corvex, Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.